investor login

contact

team

dedicated funds

news

 portfolio

Provider of a histotripsy platform designed for the treatment of cancer. The company’s platform uses robotically assisted non-invasive, pulsed sound energy applied from outside the body, which can be used to destroy tissue at the cellular and sub-cellular level, along with an embedded imaging array that provides real-time visual feedback of tissue destruction, to safely, precisely and effectively destroy unwanted tissue throughout the body, reducing patient trauma and healthcare costs.

Acquired by Bezos Expeditions, Wellington K5 Global 2025

 

VISIT WEBSITE

Exited, HOF I, HVP III, Med Tech

back to portfolio

contact

© hatteras venture partners | all rights reserved | terms + privacy | site credit

 team

 portfolio

news

home

Hatteras Venture Partners is a venture capital firm that builds transformational companies in areas of health innovation.

dedicated funds

contact

 team

dedicated funds

news

home

 portfolio